[{"Assets_0_Q1_USD":2202900000.0,"CommonStockSharesOutstanding_0_Q1_shares":47014536.0,"EarningsPerShareBasic_1_Q1_USD":0.43,"EarningsPerShareDiluted_1_Q1_USD":0.43,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":26300000.0,"NetIncomeLoss_1_Q1_USD":20200000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":156400000.0,"StockholdersEquity_0_Q1_USD":1251800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":46900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":46900000.0,"Ticker":"AVNS","CIK":"1606498","name":"HALYARD HEALTH, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20180502"}]